Aerie Pharmaceuticals Inc (AERI) - Financial and Strategic SWOT Analysis Review

April 2021 | 53 pages | ID: AE815F3FB9AAEN
GlobalData

Abstracts

Aerie Pharmaceuticals Inc (AERI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Aerie Pharmaceuticals Inc (Aerie) is a pharmaceutical company that discovers, develops and commercializes therapies for the treatment of patients with glaucoma and other diseases of the eye. The company’s product candidates comprise rhopressa, a once-daily eye drop which is used for the reduction of intraocular pressure in patients with glaucoma or ocular hypertension; and roclatan, a fixed-dose combination of rhopressa and latanoprost. Aerie works in partnership with other pharma companies and universities for drug discovery technologies. The company has presence in the US and Ireland. Aerie is headquartered in Durham, North Carolina, the US.

Aerie Pharmaceuticals Inc Key Recent Developments

Apr 07,2021: Aerie Pharmaceuticals to Participate in the 20th Annual Needham Virtual Healthcare Conference
Mar 11,2021: Aerie Pharmaceuticals to Participate in the Oppenheimer 31st Annual Virtual Healthcare Conference
Feb 25,2021: Aerie Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
Feb 22,2021: Aerie Pharmaceuticals to Participate in Upcoming Virtual Investor Conferences
Feb 18,2021: Aerie Pharmaceuticals to Announce Fourth Quarter and Full Year 2020 Financial Results and Host Conference Call on Thursday, February 25, 2021

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Aerie Pharmaceuticals Inc - Key Facts
Aerie Pharmaceuticals Inc - Key Employees
Aerie Pharmaceuticals Inc - Key Employee Biographies
Aerie Pharmaceuticals Inc - Major Products and Services
Aerie Pharmaceuticals Inc - History
Aerie Pharmaceuticals Inc - Company Statement
Aerie Pharmaceuticals Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Aerie Pharmaceuticals Inc - Business Description
R&D Overview
Aerie Pharmaceuticals Inc - SWOT Analysis
SWOT Analysis - Overview
Aerie Pharmaceuticals Inc - Strengths
Aerie Pharmaceuticals Inc - Weaknesses
Aerie Pharmaceuticals Inc - Opportunities
Aerie Pharmaceuticals Inc - Threats
Aerie Pharmaceuticals Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Aerie Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Aerie Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Aerie Pharmaceuticals Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Apr 07, 2021: Aerie Pharmaceuticals to Participate in the 20th Annual Needham Virtual Healthcare Conference
Mar 11, 2021: Aerie Pharmaceuticals to Participate in the Oppenheimer 31st Annual Virtual Healthcare Conference
Feb 25, 2021: Aerie Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
Feb 22, 2021: Aerie Pharmaceuticals to Participate in Upcoming Virtual Investor Conferences
Feb 18, 2021: Aerie Pharmaceuticals to Announce Fourth Quarter and Full Year 2020 Financial Results and Host Conference Call on Thursday, February 25, 2021
Nov 05, 2020: Aerie Pharmaceuticals reports third quarter 2020 financial results and provides business update
Aug 06, 2020: Aerie Pharmaceuticals reports second quarter 2020 financial results and provides business update
Jun 11, 2020: Aerie Pharmaceuticals appoints Peter J. McDonnell, M.D., to the company’s board of directors
May 06, 2020: Aerie Pharmaceuticals reports first quarter 2020 financial results and provides business update
Apr 09, 2020: Aerie Pharmaceuticals provides 2020 company and guidance update associated with COVID-19

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Aerie Pharmaceuticals Inc, Key Facts
Aerie Pharmaceuticals Inc, Key Employees
Aerie Pharmaceuticals Inc, Key Employees (cont..)
Aerie Pharmaceuticals Inc, Key Employee Biographies
Aerie Pharmaceuticals Inc, Major Products and Services
Aerie Pharmaceuticals Inc, History
Aerie Pharmaceuticals Inc, Other Locations
Aerie Pharmaceuticals Inc, Subsidiaries
Aerie Pharmaceuticals Inc, Key Competitors
Aerie Pharmaceuticals Inc, Ratios based on current share price
Aerie Pharmaceuticals Inc, Annual Ratios
Aerie Pharmaceuticals Inc, Annual Ratios (Cont...1)
Aerie Pharmaceuticals Inc, Interim Ratios
Aerie Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Aerie Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Aerie Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Aerie Pharmaceuticals Inc, Performance Chart (2016 - 2020)
Aerie Pharmaceuticals Inc, Ratio Charts
Aerie Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Aerie Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021